Pàgina inicial > Resultats de la cerca: Steg, P.G.
  Consells de cerca
Cerca avançada
Cerca col·leccions:
Ordena'ls per: Mostrar els resultats: Format de visualizació:
Resultats globals: 4 registres trobats en 0.02 segons.
Articles, 4 registres trobats
Articles 4 registres trobats  
1.
10 p, 396.0 KB Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events : The ODYSSEY OUTCOMES Trial / Szarek, Michael (State University of New York) ; White, Harvey D. (University of Auckland and Green Lane Cardiovascular Services Auckland City Hospital) ; Schwartz, Gregory G. (Division of Cardiology. University of Colorado School of Medicine) ; Alings, Marco (Amphia Ziekenhuis Molengracht) ; Bhatt, Deepak L (Brigham and Women's Hospital Heart & Vascular Center and Harvard Medical School) ; Bittner, Vera A. (University of Alabama at Birmingham) ; Chiang, Chern-En (Taipei Veterans General Hospital and National Yang-Ming University) ; Diaz, Rafael (Instituto Cardiovascular de Rosario) ; Edelberg, Jay M. (Sanofi) ; Goodman, Shaun G. (University of Toronto) ; Hanotin, Corinne (Sanofi) ; Harrington, R.A. (Stanford University) ; Jukema, J.Wouter (Leiden University Medical Center) ; Kimura, Takeshi (Kyoto University Graduate School of Medicine) ; Kiss, Robert Gabor (Magyar Honvédség Egészségügyi Központ) ; Lecorps, Guillaume (Sanofi) ; Mahaffey, Kenneth W. (Stanford University) ; Moryusef, Angèle (Sanofi) ; Pordy, Robert (Regeneron Pharmaceuticals Inc.) ; Roe, Matthew T. (Duke University Medical Center) ; Tricoci, Pierluigi (Duke University Medical Center) ; Xavier, Denis (St. John's Medical College and Research Institute) ; Zeiher, Andreas Michael (Goethe University) ; Steg, Ph Gabriel (Royal Brompton Hospital (Londres)) ; Cequier Fillat, Angel R. (Hospital Universitari de Bellvitge) ; Garcia-Dorado, David (Hospital Universitari Vall d'Hebron) ; Matas Pericas, Laia (Institut d'Investigació Biomèdica Sant Pau) ; Bruguera Cortada, Jordi (Hospital del Mar (Barcelona, Catalunya)) ; Gusi Tragant, Gabriel (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Coca Payeras, Antonio (Hospital Clínic i Provincial de Barcelona) ; Universitat Autònoma de Barcelona
The ODYSSEY OUTCOMES (Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab) trial compared alirocumab with placebo, added to high-intensity or maximum-tolerated statin treatment, after acute coronary syndrome (ACS) in 18,924 patients. [...]
2019 - 10.1016/j.jacc.2018.10.039
Journal of the American College of Cardiology, Vol. 73 Núm. 4 (may 2019) , p. 387-396  
Registre complet - Creative Commons
2.
10 p, 324.1 KB Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome : ODYSSEY OUTCOMES Trial / Jukema, J.Wouter (Leiden University Medical Center) ; Szarek, Michael (State University of New York) ; Zijlstra, Laurien E. (Leiden University Medical Center) ; de Silva, H.Asita (University of Kelaniya) ; Bhatt, Deepak L (Brigham and Women's Hospital Heart & Vascular Center and Harvard Medical School) ; Bittner, Vera A. (University of Alabama at Birmingham) ; Diaz, Rafael (Cardiovascular Institute of Rosario) ; Edelberg, Jay M. (Sanofi) ; Goodman, Shaun G. (St. Michael's Hospital. University of Toronto) ; Hanotin, Corinne (Sanofi) ; Harrington, Robert A. (Stanford University) ; Karpov, Yuri (Russian Cardiological Scientific-Productive Complex) ; Moryusef, Angèle (Sanofi) ; Pordy, Robert (Regeneron Pharmaceuticals. Inc.) ; Prieto, Juan C. (University of Chile Clinical Hospital) ; Roe, Matthew T. (Duke University School of Medicine) ; White, Harvey D. (Green Lane Cardiovascular Services Auckland City Hospital) ; Zeiher, Andreas Michael (Goethe University) ; Schwartz, Gregory G. (University of Colorado School of Medicine) ; Steg, P.Gabriel (Royal Brompton Hospital (Londres)) ; Cequier, Ángel (Hospital Universitari de Bellvitge) ; García-Dorado, David (Hospital Universitari Vall d'Hebron) ; Mata Pericas, Laia (Institut d'Investigació Biomèdica Sant Pau) ; Bruguera Cortada, Jordi (Hospital del Mar (Barcelona, Catalunya)) ; Gusi Tragant, Gabriel (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Coca Payeras, Antonio (Hospital Clínic i Provincial de Barcelona) ; Universitat Autònoma de Barcelona
Patients with acute coronary syndrome (ACS) and concomitant noncoronary atherosclerosis have a high risk of major adverse cardiovascular events (MACEs) and death. The impact of lipid lowering by proprotein convertase subtilisin-kexin type 9 inhibition in such patients is undetermined. [...]
2019 - 10.1016/j.jacc.2019.03.013
Journal of the American College of Cardiology, Vol. 74 Núm. 9 (march 2019) , p. 1167-1176  
Registre complet - Creative Commons
3.
15 p, 745.4 KB Chronic kidney disease has a graded association with death and cardiovascular outcomes in stable coronary artery disease : An analysis of 21,911 patients from the CLARIFY registry / Vidal-Petiot, Emmanuelle (Institut nationale de la santé et de la recherché médicale) ; Greenlaw, Nicola (University of Glasgow) ; Kalra, Paul R. (Portsmouth Hospitals NHS Trust) ; Garcia-Moll, Xavier (Institut d'Investigació Biomèdica Sant Pau) ; Tardif, Jean-Claude (Université de Montreal) ; Ford, Ian (University of Glasgow) ; Zamorano, Jose (Hospital Universitari Ramon y Cajal) ; Ferrari, Roberto (Maria Cecilia Hospital) ; Tendera, Michal (Medical University of Silesia) ; Fox, Kim M. (Royal Brompton Hospital (Londres)) ; Steg, Philippe Gabriel (Hôpital Bichat) ; Universitat Autònoma de Barcelona
Chronic kidney disease (CKD) is associated with an increased cardiovascular risk in a broad spectrum of populations. However, the risk associated with a reduced estimated glomerular filtration rate (eGFR) in patients with stable coronary artery disease receiving standard care in the modern era, independently of baseline cardiovascular disease, risk factors, and comorbidities, remains unclear. [...]
2020 - 10.3390/jcm9010004
Journal of clinical medicine, Vol. 9 Núm. 1 (january 2020) , p. 4  
Registre complet - Creative Commons
4.
12 p, 648.4 KB Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome / Bittner, Vera A. (University of Alabama at Birmingham) ; Szarek, Michael (State University of New York) ; Aylward, Philip (South Australian Health and Medical Research Institute) ; Bhatt, Deepak L. (Brigham and Women's Hospital Heart & Vascular Center and Harvard Medical School) ; Díaz, Rafaël J. (Instituto Cardiovascular de Rosario) ; Edelberg, Jay M. (Sanofi) ; Fras, Zlatko (Univerza V Ljubljani) ; Goodman, Shaun G. (University of Toronto) ; Halvorsen, Sigrun (University of Oslo) ; Hanotin, Corinne (Sanofi) ; Harrington, Robert A. (Stanford University) ; Jukema, J. Wouter (Leiden University Medical Center) ; Loizeau, Virginie (Sanofi) ; Moriarty, Patrick Maurice (University of Kansas Medical Center) ; Moryusef, Angèle (Sanofi) ; Pordy, Robert (Regeneron Pharmaceuticals Inc.) ; Roe, Matthew T. (Duke University School of Medicine) ; Sinnaeve, Peter (University of Leuven) ; Tsimikas, Sotirios (University of California San Diego) ; Vogel, Robert A. (University of Colorado School of Medicine) ; White, Harvey D. (Green Lane Cardiovascular Services Auckland City Hospital) ; Zahger, Doron (Soroka University Medical Center) ; Zeiher, Andreas Michael (Goethe University) ; Steg, Philippe Gabriel (Royal Brompton Hospital (Londres)) ; Schwartz, Gregory G. (University of Colorado School of Medicine) ; Matas Pericas, Laia (Institut d'Investigació Biomèdica Sant Pau) ; Gusi Tragant, Gabriel (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Coca Payeras, Antonio (Hospital Clínic i Provincial de Barcelona) ; Cequier, Ángel (Hospital Universitari de Bellvitge) ; García-Dorado, David (Hospital Universitari Vall d'Hebron) ; Bruguera Cortada, Jordi (Hospital del Mar (Barcelona, Catalunya)) ; Universitat Autònoma de Barcelona
Lipoprotein(a) concentration is associated with cardiovascular events. Alirocumab, a proprotein convertase subtilisin/kexin type 9 inhibitor, lowers lipoprotein(a) and low-density lipoprotein cholesterol (LDL-C). [...]
2020 - 10.1016/j.jacc.2019.10.057
Journal of the American College of Cardiology, Vol. 75 Núm. 2 (21 2020) , p. 133-144  
Registre complet - Creative Commons

Vegeu també: autors amb noms similars
1 Steg, P.Gabriel
1 Steg, Ph Gabriel
3 Steg, Philippe Gabriel
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.
Dipòsit Digital de Documents de la UAB :: Cerca :: Lliura :: Personalitza :: Ajuda
Powered by Invenio v1.1.6
Mantingut per ddd.bib@uab.cat  :: Metadades subjectes a:
Col·laborem